BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34411399)

  • 1. Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: A systematic review and meta-analysis.
    Zhang Y; Qin X; Chen W; Liu D; Luo J; Wang H; Wang H
    Colorectal Dis; 2021 Nov; 23(11):2846-2858. PubMed ID: 34411399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for appendiceal and colorectal peritoneal metastases.
    Enblad M; Graf W; Birgisson H
    Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
    Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
    Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
    van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer?
    Honoré C; Gelli M; Francoual J; Benhaim L; Elias D; Goéré D
    Int J Hyperthermia; 2017 Aug; 33(5):505-510. PubMed ID: 28540831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study.
    Bhatt A; Bhamre R; Rohila J; Kalikar V; Desouza A; Saklani A
    Colorectal Dis; 2019 Mar; 21(3):287-296. PubMed ID: 30457185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Klaver CEL; van Huijgevoort NCM; de Buck van Overstraeten A; Wolthuis AM; Tanis PJ; van der Bilt JDW; Sagaert X; D'Hoore A
    Ann Surg Oncol; 2018 Jan; 25(1):212-220. PubMed ID: 29076043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
    Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
    Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
    Baratti D; Kusamura S; Iusco D; Gimondi S; Pietrantonio F; Milione M; Guaglio M; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Ann Surg Oncol; 2017 Jan; 24(1):167-175. PubMed ID: 27519353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
    de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
    Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.
    Miyake H; Murono K; Nagata H; Nozawa H; Kawai K; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Ishihara S
    Int J Colorectal Dis; 2019 May; 34(5):801-809. PubMed ID: 30739186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.
    Lurvink RJ; Rijken A; Bakkers C; Lemmens VE; de Reuver PR; Tuynman JB; Kok NF; Nienhuijs SW; van Erning FN; de Hingh IHJT
    Surg Endosc; 2022 Sep; 36(9):6551-6557. PubMed ID: 35059835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer: a systematic review.
    Honoré C; Goéré D; Souadka A; Dumont F; Elias D
    Ann Surg Oncol; 2013 Jan; 20(1):183-92. PubMed ID: 23090572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of curative treatment for colorectal liver metastases combined with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases: a systematic review and meta-analysis of current evidence.
    Zou Y; Chen X; Zhang X; Shen Z; Cai J; Tan Y; Weng J; Rong Y; Lin X
    Int J Hyperthermia; 2020; 37(1):944-954. PubMed ID: 32787474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
    Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
    Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study.
    El Asmar A; Demetter P; Fares F; Sclafani F; Hendlisz A; Donckier V; Vermeulen P; Liberale G
    Ann Surg Oncol; 2023 Jun; 30(6):3320-3328. PubMed ID: 36754942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
    Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
    Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous and Signet Ring Cell Differentiation Affect Patterns of Metastasis in Colorectal Carcinoma and Influence Survival.
    Kermanshahi TR; Magge D; Choudry H; Ramalingam L; Zhu B; Pingpank J; Ahrendt S; Holtzman M; Zeh H; Bartlett D; Zureikat A; Pai RK
    Int J Surg Pathol; 2017 Apr; 25(2):108-117. PubMed ID: 27571790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.